Data / Form D filings / AMORCYTE INC
AMORCYTE INC: Form D filings
AMORCYTE INC, a biotechnology company in Allendale, NJ, filed 2 Form D notices with the SEC between 2010 and 2011. The latest, on July 21, 2011, reports $500,000 sold of a $1.2 million offering to 1 investor.
Find out what AMORCYTE INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4 PEARL COURT, SUITE C, Allendale, NJ, 07401
- Phone
- (201) 883-5314
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1349940
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 21, 2011 | New notice | $1,200,000 | $500,000 | $700,000 | 1 | Jul 13, 2011 | sec.gov |
| Nov 24, 2010 | New notice | $800,000 | $525,000 | $275,000 | 9 | Nov 19, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Darren J. Blanton | Director | |
| Hans J. Mueller | Director | |
| Michael J. Starcher | Director | |
| Desmond J. O'Connell | Director | |
| Andrew J. Pecora | Executive Officer | |
| George J. Goldberger | Executive Officer | |
| Paul J. Schmitt | Director, Executive Officer |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
Every Form D from the week of Jul 18, 2011 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AMORCYTE INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.